U.S. Markets closed

That Marketing Solution, Inc. (OTCBB: TSTS) Receives Its First Order to Produce a Micellized Ingredient Using Their Proprietary Aqua V Manufacturing Process

SALT LAKE CITY, UT--(Marketwired - Feb 23, 2015) - That Marketing Solution, Inc. (OTCBB: TSTS) is pleased to announce they have received their first order to micellize a specific ingredient for a third party. Due to the restrictions of an NDA we will not be disclosing the client or the specific ingredient at this time. We can say the client is considered a market leader within a specific billion-dollar market sector.

"We anticipate this is the first of many orders from this particular client," said President of TSTS, Matt Smith. "We know we have something unique with our micellized manufacturing process that can give our clients a competitive advantage in the marketplace."

About That Marketing Solution, Inc (TSTS): That Marketing Solution Develops and Markets Health Related Products. The company owns and operates Technology around Micellization Manufacturing Process. This Proprietary Micellization Process converts oil based nutrients into water soluble products for better absorption by the cells. For more information visit www.ThatMarketingSolution.com.

About TSTS's Aqua V Technology: The Aqua V Technology is an important scientific discovery that exponentially increases the nutritional benefits of bio-nutrients to the body, while lowering the amount of raw ingredients required to manufacture the nutritional formula. Many of the most important bio-nutrients that people supplement in their diets are fat-soluble. Therefore, the body must micellize the supplement by breaking it down -- which leaves only a portion of the bio-nutrient available for uptake. By using this proprietary technology to adapt the nutrient outside of the body, the uptake is almost immediate, and the formulation has almost no bio-waste in the process. This allows formulators to use less active ingredient in their formulas to get the maximum benefit, and, it controls the delivery of the exact amount of nutritional value to the body.

Safe Harbor: This presentation contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the presentation, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this presentation.